Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Regadenoson: a focused update.

Ghimire G, Hage FG, Heo J, Iskandrian AE.

J Nucl Cardiol. 2013 Apr;20(2):284-8. doi: 10.1007/s12350-012-9661-3. Review.

PMID:
23229649
2.

The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial.

Ballany W, Mansour K, Morales Demori R, Al-Amoodi M, Doukky R.

J Nucl Cardiol. 2014 Jun;21(3):496-502. doi: 10.1007/s12350-014-9864-x. Epub 2014 Feb 12.

PMID:
24519563
3.

A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.

Parker MW, Morales DC, Slim HB, Ahlberg AW, Katten DM, Cyr G, Mathur S, Ardestani A, Barmpouletos D, Iyah GS, Borer SM, Heller GV.

J Nucl Cardiol. 2013 Apr;20(2):185-96. doi: 10.1007/s12350-012-9641-7. Epub 2012 Nov 28.

PMID:
23188626
4.

Regadenoson-stress myocardial CT perfusion and single-photon emission CT: rationale, design, and acquisition methods of a prospective, multicenter, multivendor comparison.

Cury RC, Kitt TM, Feaheny K, Akin J, George RT.

J Cardiovasc Comput Tomogr. 2014 Jan-Feb;8(1):2-12. doi: 10.1016/j.jcct.2013.09.004. Epub 2013 Oct 18.

PMID:
24314823
5.

Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial.

Ross MI, Wu E, Wilkins JT, Gupta D, Shen S, Aulwes D, Montero K, Holly TA.

J Nucl Cardiol. 2013 Apr;20(2):197-204. doi: 10.1007/s12350-013-9679-1. Epub 2013 Feb 13.

PMID:
23404232
6.

The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.

Doukky R, Fughhi I, Campagnoli T, Wassouf M, Ali A.

J Nucl Cardiol. 2017 Feb;24(1):112-118. doi: 10.1007/s12350-015-0303-4. Epub 2015 Nov 18.

PMID:
26582040
7.

A useful and easy to develop combined stress test for myocardial perfusion imaging: Regadenoson and isometric exercise, preliminary results.

Janvier L, Pinaquy J, Douard H, Karcher G, Bordenave L.

J Nucl Cardiol. 2017 Feb;24(1):34-40. doi: 10.1007/s12350-015-0278-1. Epub 2015 Nov 5.

PMID:
26542990
8.

Regadenoson for myocardial perfusion imaging: Is it safe?

Hage FG.

J Nucl Cardiol. 2014 Oct;21(5):871-6. doi: 10.1007/s12350-014-9922-4. Epub 2014 Jun 19. No abstract available. Erratum in: J Nucl Cardiol. 2014 Dec;21(6):1266.

PMID:
24939324
9.

Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.

Mahmarian JJ, Peterson LE, Xu J, Cerqueira MD, Iskandrian AE, Bateman TM, Thomas GS, Nabi F.

J Nucl Cardiol. 2015 Apr;22(2):248-61. doi: 10.1007/s12350-014-9981-6. Epub 2014 Oct 7.

PMID:
25287737
10.

Regadenoson: a new myocardial stress agent.

Al Jaroudi W, Iskandrian AE.

J Am Coll Cardiol. 2009 Sep 22;54(13):1123-30. doi: 10.1016/j.jacc.2009.04.089. Review. Erratum in: J Am Coll Cardiol. 2009 Oct 20;54(17):1635.

11.

Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging.

Lester D, El-Hajj S, Farag AA, Bhambhvani P, Tauxe L, Heo J, Iskandrian AE, Hage FG.

J Nucl Cardiol. 2016 Oct;23(5):1147-1155. doi: 10.1007/s12350-015-0272-7. Epub 2015 Oct 21.

PMID:
26490267
12.

[Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].

Jager PL, Buiting M, Mouden M, Oostdijk AH, Timmer J, Knollema S.

Rev Esp Med Nucl Imagen Mol. 2014 Nov-Dec;33(6):346-51. doi: 10.1016/j.remn.2014.04.004. Epub 2014 May 23. Spanish.

13.

Serious complications associated with regadenoson administration for myocardial perfusion imaging.

Kitt T, Jiang J.

J Nucl Cardiol. 2015 Apr;22(2):395. doi: 10.1007/s12350-014-0048-5. Epub 2014 Dec 30. No abstract available.

14.

Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary.

Hage FG, Iskandrian AE.

J Nucl Cardiol. 2014 Oct;21(5):877-9. doi: 10.1007/s12350-014-9985-2. No abstract available.

PMID:
25156654
15.

Outcome of patients with regadenoson-induced ST-segment depression but normal perfusion on single-photon emission computed tomography.

Uthamalingam S, Gurm GS, Ahmado I, Sidhu MS, Flynn J.

Angiology. 2013 Jan;64(1):46-8. doi: 10.1177/0003319711436073. Epub 2012 Feb 8.

PMID:
22323835
16.

Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge.

Golzar Y, Doukky R.

Int J Chron Obstruct Pulmon Dis. 2014 Jan 22;9:129-37. doi: 10.2147/COPD.S56879. eCollection 2014. Review.

17.

Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging.

Farzaneh-Far A, Shaw LK, Dunning A, Oldan JD, O'Connor CM, Borges-Neto S.

J Nucl Cardiol. 2015 Aug;22(4):600-7. doi: 10.1007/s12350-015-0155-y. Epub 2015 May 19.

PMID:
25987234
18.

Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.

Tejani FH, Thompson RC, Iskandrian AE, McNutt BE, Franks B.

J Nucl Cardiol. 2011 Feb;18(1):73-81. doi: 10.1007/s12350-010-9311-6. Epub 2010 Nov 17.

PMID:
21082298
19.

Asystole following regadenoson infusion in stable outpatients.

Rosenblatt J, Mooney D, Dunn T, Cohen M.

J Nucl Cardiol. 2014 Oct;21(5):862-8. doi: 10.1007/s12350-014-9898-0. Epub 2014 May 31.

PMID:
24879452
20.

Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial.

Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, Lieu H, Mahmarian JJ, Olmsted A, Underwood SR, Vitola J, Wang W; ADVANCE MPI Investigators.

J Nucl Cardiol. 2007 Sep-Oct;14(5):645-58.

PMID:
17826318

Supplemental Content

Support Center